Literature DB >> 11310443

Virulence factors of Helicobacter pylori.

W G Dundon1, M de Bernard, C Montecucco.   

Abstract

To date a number of virulence factors have been identified and characterised from the gastric pathogen Helicobacter pylori. The vacuolating toxin (VacA) is a major determinant of H. pylori-associated gastric disease. In non-polarised cells, VacA alters the endocytic pathway, resulting in the release of acid hydrolases and the reduction of both extracellular ligand degradation and antigen processing. The toxin forms trans-membrane anion-specific channels and reduces the transepithelial electrical resistance of polarized monolayers. Localization of the VacA channels in acidic intracellular compartments causes osmotic swelling which, together with membrane fusion, leads to vacuole formation. The neutrophil-activating protein of H. pylori (HP-NAP) induces the production of oxygen radicals in human neutrophils via a cascade of intracellular activation events which may contribute to the damage of the stomach mucosa. This protein has recently been shown to be an important antigen in the human immune response to H. pylori infection. In addition, mice vaccinated with recombinant HP-NAP were protected against H. pylori challenge. H. pylori strains that are associated with severe tissue damage and inflammation possess the cag pathogenicity island that contains several genes encoding factors involved in the induction of proinflammatory cytokines/chemokines and of a type IV secretion system involved in the delivery of a highly immunogenic protein, CagA, into eukaryotic cells. Recent advances in our understanding of the involvement of VacA, HP-NAP and the CagA/Type IV secretion system in the H. pylori-associated disease process are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11310443     DOI: 10.1016/s1438-4221(01)80002-3

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  13 in total

1.  Characterization of peptidoglycan hydrolase in Cag pathogenicity island of Helicobacter pylori.

Authors:  Qiao Zhong; Shihe Shao; Runhong Mu; Hua Wang; Shiteng Huang; Jun Han; He Huang; Shuwei Tian
Journal:  Mol Biol Rep       Date:  2010-04-01       Impact factor: 2.316

2.  Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agent.

Authors:  Ludwig Deml; Michael Aigner; Jochen Decker; Alexander Eckhardt; Christian Schütz; Peer R E Mittl; Sascha Barabas; Stefanie Denk; Gertrud Knoll; Norbert Lehn; Wulf Schneider-Brachert
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 3.  Medicinal plant activity on Helicobacter pylori related diseases.

Authors:  Yuan-Chuen Wang
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

4.  A role for CagA/VacA in Helicobacter pylori inhibition of murine duodenal mucosal bicarbonate secretion.

Authors:  Bi-Guang Tuo; Zachary M Sellers; Anders J Smith; Kim E Barrett; Jon I Isenberg; Hui Dong
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

5.  Growth phase-dependent regulation of target gene promoters for binding of the essential orphan response regulator HP1043 of Helicobacter pylori.

Authors:  Isabel Delany; Gunther Spohn; Rino Rappuoli; Vincenzo Scarlato
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

6.  The effect of different strains of Helicobacter pylori on platelet aggregation.

Authors:  Paul A Corcoran; John C Atherton; Steve W Kerrigan; Torkel Wadstrom; Frank E Murray; Richard M Peek; Desmond J Fitzgerald; Dermont M Cox; Michael F Byrne
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

Review 7.  Pathogenicity islands in bacterial pathogenesis.

Authors:  Herbert Schmidt; Michael Hensel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

8.  Helicobacter pylori induces activation of human peripheral γδ+ T lymphocytes.

Authors:  Benedetta Romi; Elisabetta Soldaini; Laura Pancotto; Flora Castellino; Giuseppe Del Giudice; Francesca Schiavetti
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

9.  In-silico design, synthesis, ADMET studies and biological evaluation of novel derivatives of Chlorogenic acid against Urease protein and H. Pylori bacterium.

Authors:  Ritu Kataria; Anurag Khatkar
Journal:  BMC Chem       Date:  2019-03-28

10.  Multiplex-PCR-Based Screening and Computational Modeling of Virulence Factors and T-Cell Mediated Immunity in Helicobacter pylori Infections for Accurate Clinical Diagnosis.

Authors:  Sinem Oktem-Okullu; Arzu Tiftikci; Murat Saruc; Bahattin Cicek; Eser Vardareli; Nurdan Tozun; Tanil Kocagoz; Ugur Sezerman; Ahmet Sinan Yavuz; Ayca Sayi-Yazgan
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.